UT psychology professor Ralph Lydic recently led a study about a drug used to treat opioid addiction, according to WVLT. The study examined buprenorphine, a scheduled III drug believed to have a lower abuse potential than methadone.
“The discovery of the drug’s previously unknown side effect could help clinicians improve patient care,” Lydic said.
UT researchers said the study’s findings now present a challenge for clinical providers to slash the drug cravings of addiction patients without seeing a possible spike in respiratory depression.